The UK Interstitial Lung Disease Long-COVID19 Study (UKILD-Long COVID): Understanding the Burden of Interstitial Lung Disease in Long COVID.

NCT05514522 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2023-11-15

No results posted yet for this study

Summary

Prospective observational study of hospitalised and non-hospitalised patients post- infection with SARS-CoV-2. The study aims to recruit 2000 individuals, with proven COVID-19, who were not hospitalised but presented to Long-COVID clinics with persistent respiratory symptoms such as breathlessness or cough and are referred for cross-sectional imaging (computer tomography, CT) at baseline (3 months weeks after their first COVID-19 symptoms). The study will run for 18 months.

Conditions

Sponsors & Collaborators

  • Medical Research Council

    collaborator OTHER_GOV
  • University of Nottingham

    collaborator OTHER
  • University of Southampton

    collaborator OTHER
  • University of Leicester

    collaborator OTHER
  • University of Manchester

    collaborator OTHER
  • University of Liverpool

    collaborator OTHER
  • University of Sheffield

    collaborator OTHER
  • University of Oxford

    collaborator OTHER
  • University College, London

    collaborator OTHER
  • University of Newcastle Upon-Tyne

    collaborator OTHER
  • University of Edinburgh

    collaborator OTHER
  • Imperial College London

    lead OTHER

Principal Investigators

  • Gisl Jenkins · Imperial College London

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-18
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05514522 on ClinicalTrials.gov